Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Prospective Study in Subjects with Late-onset Pompe Disease who are Currently Being Treated with Enzyme Replacement Therapy

Trial Profile

A Prospective Study in Subjects with Late-onset Pompe Disease who are Currently Being Treated with Enzyme Replacement Therapy

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 21 Dec 2018

At a glance

  • Drugs ATB 200 (Primary)
  • Indications Glycogen storage disease type II
  • Focus Therapeutic Use
  • Acronyms STRIDE
  • Sponsors Amicus Therapeutics
  • Most Recent Events

    • 06 Oct 2018 This trial has been completed in Belgium.
    • 03 Oct 2018 Status has been changed to discontinued.
    • 03 Jul 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top